Mycophenolate Mofetil in Membranous Nephropathy

NCT00135967 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis, Membranous

Interventions

DRUG: mycophenolate mofetil orally 1000 mg twice a day (BID)
DRUG: prednisone 0,5 mg/kg orally on alternate days
DRUG: intravenous (i.v.) methylprednisolone 1000 mg, total 9

Sponsor

Radboud University Medical Center

Collaborators

[object Object]